Who is sponsoring NCT04081311?

NCT04081311 is sponsored by University of Manitoba.

What drugs are being tested in NCT04081311?

Interventions in NCT04081311: comparing interdental floss to water flosser around dental implants.

What condition does NCT04081311 study?

NCT04081311 studies Implant Site Bleeding.

Is NCT04081311 still recruiting?

NCT04081311 is currently completed. Last updated 30 April 2021.

Last reviewed 2021-04-30 · How we verify

NCT04081311

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparison of the Efficacy of Interdental Floss to Water Flosser Around Dental Implants

Completed NA Last updated 30 April 2021

What this trial tests

NA trial testing comparing interdental floss to water flosser around dental implants in Implant Site Bleeding in 33 participants. Completed in 31 March 2021.

Timeline

6 September 2019

Primary endpoint
31 March 2021

31 March 2021

Quick facts

Lead sponsor	University of Manitoba
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	33
Start date	6 September 2019
Primary completion	31 March 2021
Estimated completion	31 March 2021
Sites	1 location across Canada

Drugs / interventions tested

comparing interdental floss to water flosser around dental implants

Conditions studied

Implant Site Bleeding — all drugs for Implant Site Bleeding →

Sponsor

University of Manitoba

Who can join

18 and older, any sex, with Implant Site Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study was to compare two different interproximal devices, water flosser and dental floss around implants in several clinical parameters

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04081311 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 30 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04081311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing